Jeffrey G. Black
Chief Accounting Officer, Verenium Corporation.
Companies
- Exagen Inc.Chief financial officer Sep 4, 2024 to now1
- Standard BioTools Inc.Chief financial officer May 17, 2023 to Sep 5, 20242
- Apollo Endosurgery (United States)Chief financial officer Aug 6, 2021 to Apr 4, 20233
- Alphatec Holdings, Inc.Chief financial officer Mar 15, 2017 to Mar 10, 20214
- Verenium CorporationChief financial officer Aug 16, 2011 to Nov 4, 20135
- Verenium CorporationChief Accounting Officer Nov 6, 2008 to Mar 1, 20116
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Exagen Inc. XGN324,910 shares7$2.4M at $7.40Sep 1, 2026- Standard BioTools Inc. LAB421,608 shares8$269.5K at $0.64Aug 20, 2024
Apollo Endosurgery (United States)0 shares9Apr 4, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 1, 2026Granted 1,571 shares at $3.02 of Exagen Inc.7
- Sep 1, 2026Sold 20,614 shares at $7.22 of Exagen Inc.7
- Mar 12, 2026Granted 75,000 shares at $3.16 of Exagen Inc.10
- Feb 27, 2026Granted 1,511 shares at $3.08 of Exagen Inc.10
- Feb 24, 2026Sold 1,584 shares at $3.61 of Exagen Inc.11
- Sep 2, 2025Sold 20,466 shares at $9.79 of Exagen Inc.12
- Feb 21, 2025Granted 15,000 shares of Exagen Inc.13
- Nov 15, 2024Bought 22,298 shares at $2.98 of Exagen Inc.14
- Sep 1, 2024Granted 225,000 shares of Exagen Inc.15
- Aug 20, 2024Shares withheld for tax 6,690 shares at $1.91 of Standard BioTools Inc.8
- Aug 15, 2024Shares withheld for tax 4,695 shares at $1.55 of Standard BioTools Inc.16
- Aug 15, 2024Exercised options 13,157 shares of Standard BioTools Inc.16
- May 20, 2024Granted 300,000 shares of Standard BioTools Inc.17
- May 15, 2024Shares withheld for tax 18,779 shares at $2.54 of Standard BioTools Inc.18
- May 15, 2024Exercised options 52,631 shares of Standard BioTools Inc.18
- May 19, 2023Bought 42,492 shares at $2.29 of Standard BioTools Inc.19
- May 18, 2023Bought 43,492 shares at $2.22 of Standard BioTools Inc.19
- Apr 4, 2023Returned to company 335,330 shares of Apollo Endosurgery (United States)9
- Nov 4, 2022Shares withheld for tax 15,060 shares at $6.46 of Apollo Endosurgery (United States)20
- Aug 5, 2022Shares withheld for tax 6,190 shares at $6.46 of Apollo Endosurgery (United States)21
- Jun 14, 2022Granted 88,900 shares of Apollo Endosurgery (United States)22
- Mar 1, 2022Bought 10,000 shares at $6.20 of Apollo Endosurgery (United States)23
- Feb 28, 2022Bought 15,000 shares at $5.66 of Apollo Endosurgery (United States)23
- Feb 25, 2022Bought 15,000 shares at $5.48 of Apollo Endosurgery (United States)23
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARExagen Inc., Chief financial officer
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Mar 16, 2026
- 11SEC EDGARForm 4 filed Feb 25, 2026
- 12SEC EDGARForm 4 filed Sep 4, 2025
- 13SEC EDGARForm 4 filed Feb 25, 2025
- 14SEC EDGARForm 4 filed Nov 19, 2024
- 15SEC EDGARForm 4 filed Sep 4, 2024
- 16SEC EDGARForm 4 filed Aug 19, 2024
- 17SEC EDGARForm 4 filed May 21, 2024
- 18SEC EDGARForm 4 filed May 16, 2024
- 19SEC EDGARForm 4 filed May 22, 2023
- 20SEC EDGARForm 4 filed Nov 4, 2022
- 21SEC EDGARForm 4 filed Aug 5, 2022
- 22SEC EDGARForm 4 filed Jun 16, 2022
- 23SEC EDGARForm 4 filed Mar 1, 2022